In familial cases of CAD, the genetic testing algorithm is based on the initial investigation of the LDLR gene, and in case of a negative result the mutations of the ApoB-100 and PCSK9 genes are tested [18]. This evidence concerns the gene LDLR and coronary artery disorder.